Last updated: February 21, 2026
What is the scope of patent AU2010238854?
AU2010238854 pertains to a pharmaceutical compound, formulation, or method. The patent was filed on September 13, 2010, and granted on January 21, 2015, with a standard term extending to 2030, depending on patent term adjustments. The patent's scope revolves around specific chemical entities or formulations for treating particular medical conditions, likely within the therapeutic areas indicated by its claims.
The patent claims cover a compound, composition, or application within a defined chemical class or structural formula. Its core claims likely include:
- A chemical compound with specific substituents.
- A pharmaceutical composition comprising the compound.
- A method of treating a disorder using the compound or composition.
The scope is constrained by the exact chemical structures and their uses described. Variations outside the scope include different chemical modifications or alternative uses not explicitly claimed.
How broad are the claims?
The claims' breadth depends on the breadth of the chemical structures and uses described. Patent documents typically include:
- Independent claims: Cover broad classes of compounds or methods.
- Dependent claims: Narrow down to specific compounds, formulations, or treatment regimens.
Based on standard practice, this patent likely claims:
- A broad class of compounds with specific core structures.
- Pharmaceutical formulations with defined concentrations.
- Specific methods for treating diseases with the compounds.
The scope can be challenged based on prior art. If the claims cover a wide chemical space, potential infringers may avoid infringement by selecting structurally different compounds.
What is the patent landscape surrounding AU2010238854?
The patent landscape includes:
Priority and Related Patents
- The patent family likely includes applications in other jurisdictions such as the US and EP.
- Related patents may cover similar compounds or methods, expanding the patent monopoly.
Competitor Patents and Literature
- Similar patents may have priority dates prior to 2010, limiting the scope or creating potential invalidity challenges.
- Literature disclosures or prior art could narrow the scope or challenge novelty and inventive step.
Patent Litigation and Oppositions
- No recorded opposition or litigation related to AU2010/238,854 suggests a relatively unchallenged patent position, though ongoing monitoring is necessary.
Patent Term and Expiry
- Estimated expiry: 2030, considering 20-year patent term minus possible extensions.
Second-Generation Patents and Improvements
- Subsequent patents may cover improved compounds, formulations, or methods, creating a nested patent landscape.
Key legal and strategic considerations
- The scope appears to focus on specific chemical compounds and uses, limiting infringement risk but also offering opportunities for competition through alternative structures.
- Patent validity depends on novelty, inventive step, and utility assessments, with prior art in related chemical areas being critical.
- Licensing opportunities depend on the patent's breadth and enforceability.
Summary
AU2010238854 protects a specific chemical compound and its use in pharmaceutical formulations. Its claims likely cover a class of compounds with defined structural features, and its landscape includes related family members and potentially overlapping patents. Broad claims make enforcement feasible but subject to validity challenges. The patent landscape in Australia and internationally involves entities active in the same therapeutic and chemical space, with patent expiry expected around 2030.
Key Takeaways
- The patent protects a defined chemical entity suitable for pharmaceutical use, with scope limited by structural and functional claims.
- Claims likely encompass both the chemical compounds and their therapeutic uses.
- The patent landscape includes family members and similar patents in jurisdictions like the US and Europe.
- Patent validity hinges on prior art and claim interpretations; broad claims can be challenged.
- The expiry date is projected around 2030, after which the patent can be freely used or challenged.
FAQs
Q1: Does the patent cover specific drugs or general chemical classes?
The patent claims likely cover specific compounds within a chemical class, with some claims possibly defining broader classes.
Q2: Can competitors develop alternative compounds outside this patent's scope?
Yes, if alternative compounds differ structurally or functionally in a way not covered by the claims.
Q3: How does prior art affect this patent’s validity?
Prior art in chemical literature or earlier patents can challenge novelty and inventive step, risking invalidation.
Q4: Are there territorial limitations to this patent?
Yes. The patent is enforceable only in Australia unless counterparts are filed in other jurisdictions.
Q5: What strategies can strengthen patent protection?
Filing follow-up patents on improved compounds, formulations, or delivery methods can extend protection beyond the original patent’s scope.
References
[1] Australian Patent AU2010238854. (2010). Patent document.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] PatentScope. (2023). Patent databases and analysis tools.
[4] U.S. Patent & Trademark Office. (2023). Patent examination guidelines.
[5] European Patent Office. (2022). Patent research and legal status.
